Login / Signup

Editorial: risk assessment for chronic hepatitis B patients in the immune tolerant phase-both definition and selection matter.

Yao-Chun HsuYen-Tsung Huang
Published in: Alimentary pharmacology & therapeutics (2020)
Keyphrases
  • risk assessment
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • hepatitis b virus
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • liver fibrosis